News

2017 Aug 07

Exciting advancements in the field of mantle cell lymphoma

John P. Leonard, M.D., professor of medicine, discusses some of the exciting advancements taking place in the field of mantle cell lymphoma (MCL). Read more

2017 Aug 04

Sequencing therapies for patients with multiple myeloma

Ruben Niesvizky, M.D. discusses sequencing agents for patients with multiple myeloma. Read more

2017 Aug 04

Challenges with CAR T-cell therapy in ALL

Gail Roboz, M.D., discusses the challenges clinicians are facing with chimeric antigen receptor (CAR) T-cell therapy in acute lymphoblastic leukemia (ALL). Read more

2017 Aug 03

Second-generation BTK inhibitors in CLL

Richard R. Furman, M.D., discusses second-generation BTK inhibitors, such as acalabrutinib and BGB-3111 in chronic lymphocytic leukemia (CLL). Read more

2017 Aug 02

Skip the Bone Marrow Biopsy in Follicular Lymphoma?

Clinical trials in patients with follicular lymphoma (FL) mandate that patients undergo bone marrow biopsies (BMBs) at baseline and at subsequent points following treatment in order to monitor response, but the biopsies are unnecessary in most patients, argues Sarah Rutherford, M.D., and colleagues. Read more

2017 Aug 02

Does radiotherapy in unresectable pancreatic cancer add value?

John Ng, M.D., reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer. Read more

2017 Aug 02

Collaborative Research Initiative announces inaugural award winners

Four interdisciplinary teams of physicians and scientists from Weill Cornell Medicine have been announced as recipients of the Sandra and Edward Meyer Cancer Center's inaugural Collaborative Research Initiative pilot project grants. Read more

2017 Jul 31

Driving discovery: Two teams uncover new player in prostate cancer formation

Scientists at the Meyer Cancer Center and Englander Institute have identified ERF as a prostate cancer tumor suppressor gene. Read more

2017 Jul 30

It doesn’t take a warrior to beat cancer. It takes a treatment that works.

Your response to treatment is a biological one, not a psychological one, asserts neurosurgeon Rohan Ramakrishna, M.D. Read more

2017 Jul 28

Mantle Cell Lymphoma: Evaluating the Treatment Landscape

Peter Martin, M.D., reviews the standards of care for mantle cell lymphoma. Read more

2017 Jul 21

Imielinski wins award from Doris Duke Charitable Foundation

Marcin Imielinski, M.D., Ph.D., has received $495,000 to investigate a potential class of genetic changes that may be driving cancer. Read more

2017 Jul 21

Dr. Bishoy Faltas wins prestigious grant from the Department of Defense

Bishoy Faltas, M.D., has been awarded a Career Development Award from the Department of Defense to investigate the biology of a family of proteins thought to drive resistance to chemotherapy in the advanced stages of bladder cancer. Read more

2017 Jul 20

McCain may benefit from glioblastoma treatment advances

Howard Fine, M.D., discusses how molecular tumor analysis is changing the landscape for brain cancer treatment. Read more

2017 Jul 11

Chromosome Rearrangements Drive Formation and Growth of Colorectal Cancer

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Weill Cornell Medicine investigators. Many of the genetic mutations... Read more

2017 Jul 11

Tackling depression and intimacy issues in patients with MPNs

Nurse Sandra Allen-Bard discusses ways in which she counsels and collects information about her patients more intimate symptoms. Read more

2017 Jul 11

‘Fusion genes’ drive formation and growth of colorectal cancer

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Lukas Dow, Ph.D. Read more